The Star-Ledger -- A jury in U.S. District Court in Texas has awarded $482 million to a Philadelphia man who claimed a Johnson & Johnson subsidiary infringed on his patent when it developed a lucrative line of drug-coated stents — tiny devices used to treat clogged heart arteries.
